News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Investor
Becton, Dickinson and Company (BDX) Board Declares Dividend 11/24/2015
AEterna Zentaris (AEZS) Announces Exercise Of Last Series B Warrants Covered By November 1, 2015 Agreement 11/24/2015
Aceto Corporation Announces The Exercise In Full Of The Over-Allotment Option In Its Convertible Notes Offering 11/24/2015
Ackman Tries to Stop the Bleeding By Increasing Valeant (VRX) Stake to 9.9% 11/24/2015
Manitex Capital Inc. Announces That Its Affiliate, Ortho Regenerative Technologies Inc., Has Filed A Preliminary Prospectus 11/24/2015
Ortho RTi Announces The Filing Of A Preliminary Prospectus 11/24/2015
Why "Price Gouging" May Come to an End 11/24/2015
Immunovia’s Share Issue Oversubscribed Five Times Prior To Listing On The Nasdaq First North In Stockholm 11/23/2015
Kitov Pharmaceuticals Holdings Announces Pricing Of U.S. Initial Public Offering And Nasdaq Listing 11/23/2015
Nuvo Research (NRI.TO) Announces TSX Conditional Approval To List Crescita Therapeutics Inc. 11/23/2015
Varian Medical Systems (VAR) Board Of Directors Authorizes Repurchase Of Additional 8 Million Shares Of Stock Through Calendar Year 2016; Also Authorizes Increase Of Existing Revolving Debt Facility From $300 Million To $500 Million 11/23/2015
Livanova To Webcast Presentations From Company's Investor And Analyst Meeting 11/23/2015
Endo International (ENDP) Announces Conditional Redemption Of All $400,000,000 Aggregate Principal Amount Outstanding Of The Two Series Of 7.00% Senior Notes Due 2020 11/23/2015
Quotient Limited (QTNTU) To Ring The NASDAQ Stock Market Closing Bell 11/23/2015
Pozen (POZN) And Tribute Provide Update On Pending Combination Transactions 11/23/2015
Air Techniques, Inc.’ New ProVecta S-Pan Cephalometric X-ray Expands The ProVecta X-ray Family 11/23/2015
Edwards Lifesciences (EW) Announces Two-for-One Stock Split 11/20/2015
Hanger (HGR) Announces Senior Notes Consent Solicitation 11/20/2015
LabStyle Innovations Closes $2.3 Million Round Of Investment From Existing Shareholders And Private Investors 11/20/2015
Xbiotech Added To The MSCI US Small Cap 1750 And The MSCI Investable Market 2500 Indexes 11/20/2015
Galectin Announces Pricing Of $9.8 Million Registered Direct Offering 11/20/2015
Newron Pharmaceuticals (NWRN) Completes 5.4 Million USD/CHF Private Placement With U.S. Biotechnology/Healthcare Specialist Fund 11/20/2015
Agilent (A) Increases Cash Dividend To 11.5 Cents Per Share 11/20/2015
Biocartis Q3 2015 Business Update 11/20/2015
Alere (ALR) Completes Divestiture Of BBI Group 11/19/2015
Aytu Bioscience To Benefit From Share Distribution By Ampio Pharmaceuticals, Inc. (AMPE) 11/19/2015
Mallinckrodt (MNK) Board Adds $500 Million To Company's Existing Share Repurchase Program 11/19/2015
Response Biomedical (RBM.V) Announces Notification Of TSX Continued Listing Review 11/19/2015
ValuationLAB Issues Research Report On Addex Therapeutics (ADXN.SW) With Share Price Estimate Of CHF5.2 Per Share 11/19/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 11/19/2015
AEterna Zentaris (AEZS) Announces Details And Implementation Of Share Consolidation To Regain NASDAQ Compliance 11/18/2015
Strongbridge Biopharma Provides Update On Corporate Progress 11/18/2015
CytoDyn Announces Investment Community Conference Call 11/18/2015
Wright Medical Group (WMGI) Announces Secondary Offering Of 4.5 Million Ordinary Shares By Selling Shareholder 11/18/2015
Ampio Pharmaceuticals, Inc. (AMPE) Announces Investor Call On Its Aytu Bioscience Common Stock Distribution On Thursday, November 19, 4:15 P.M. Estcolon Cancer Test 11/18/2015
Quest PharmaTech Inc.'s Subsidiary, OncoQuest, Closes U.S. $13,000,000 Preferred Share Private Placement With Hepalink USA To Fund Immunotherapy For Treatment Of Cancer 11/18/2015
Ampio Pharmaceuticals, Inc. (AMPE) Will Distribute Aytu Biosciences Stock To Ampio Shareholders Of Record On December 1, 2015 11/17/2015
Amatsigroup: Significant Events Of 2015 And Outlook For 2016 11/17/2015
Pressure BioSciences, Inc. (BBII) Closes Additional $745,000 Of $5 Million PIPE; Funding Received To Date Exceeds $4,000,000 11/17/2015
Allergy Therapeutics plc Release: Trading Update 11/17/2015
Thermo Fisher Scientific (TMO) Prices Offering Of Euro-Denominated Senior Notes 11/16/2015
Lipocine Inc. (LPCN) Adopts Stockholder Rights Plan 11/16/2015
Akorn, Inc. (AKN) Receives Additional Delinquency Notice From Nasdaq 11/16/2015
Mesoblast (MSB.AX) Lists On Nasdaq 11/16/2015
Erba Diagnostics Announces Delay In Filing Quarterly Report On Form 10-Q 11/16/2015
Neurotrope Announces $15.3 Million Private Placement 11/16/2015
Intuitive Surgical (ISRG) Reports New Employee Option Grants For November 2015 11/16/2015
Telesta (TSX:TST) Announces Results Of Annual General Meeting Of Shareholders 11/16/2015
Mylan (MYL) Authorizes $1 Billion Share Repurchase Plan 11/16/2015
AEterna Zentaris (AEZS) Announces Shareholder Approval Of Share Consolidation 11/16/2015
Some Pharma Companies Attempt to Keep Shares from Falling in the Hands of Activist Investors Like Ackman and Icahn 11/16/2015
After Dropping the "Biogen (BIIB) Bombshell," CEO Turns R&D Focus to Neurological Diseases Like Alzheimer's 11/13/2015
23andMe CEO Talks About Company Comeback, Embattled Theranos 11/13/2015
Thermo Fisher Scientific (TMO) Authorizes $1 Billion Of Share Repurchases And Declares Quarterly Dividend 11/13/2015
Bruker Corporation Announces New $225 Million Share Repurchase Program 11/13/2015
Mesoblast (MSB.AX) Announces Pricing Of Public Offering On Nasdaq 11/13/2015
Alcobra (ADHD) Prices Public Offering Of Ordinary Shares 11/13/2015
Cancer Genetics (CGIX) Announces Closing Of $12 Million Public Offering 11/13/2015
Nuo Therapeutics Announces Execution Of Limited Consent With Deerfield Management Through December 4, 2015 11/13/2015
Supernus Pharmaceuticals (SUPN) Announces Distribution Of Common Stock By NEA 11/13/2015
Alcobra (ADHD) Announces Proposed Public Offering Of Ordinary Shares 11/13/2015
Kraig Biocraft Laboratories, Inc. Announces Shareholder Conference Call For Friday, December 4, 2015 11/13/2015
REMINDER: Vitae Pharma (VTAE) To Host Analyst And Investor Briefing 11/13/2015
Boehringer Ingelheim Hacks Its R&D Budget to $11.8 Billion and Turns Focus on Collaborations Instead 11/12/2015
Valeant (VRX) CEO Breaks Silence, Shares Goals for Dermatology Business 11/12/2015
MannKind Corporation (MNKD) Confirms Planned Stock Sale 11/12/2015
Loxo Oncology (LOXO) Prices Follow-On Offering Of Common Stock 11/12/2015
LivaNova Provides Business Update 11/12/2015
Celsion (CLSN) Announces Dual Listing On The Tel Aviv Stock Exchange 11/12/2015
Integra LifeSciences Holdings (IART) Hosts Investor Day Today, November 12, 2015 In New York City 11/12/2015
Portola (PTLA) To Host Analyst And Investor Day On November 19 11/12/2015
AEterna Zentaris (AEZS) Announces Exercise Of Series B Warrants 11/12/2015
Aceto Corporation Announces The Pricing Of Its $125 Million Convertible Notes Offering 11/11/2015
AEterna Zentaris (AEZS) Urges Shareholders To Vote In Favor Of The Share Consolidation And Highlights Support From ISS And Glass Lewis 11/11/2015
Loxo Oncology (LOXO) Announces Proposed Public Offering Of Common Stock 11/11/2015
ZS Pharma (ZSPH) Announces New Employment Inducement Grants 11/11/2015
Skystar Bio-Pharmaceutical (CGPN) Request To Stay Nasdaq Trading Suspension Granted 11/10/2015
OncoSec Medical Inc. Closes $7.5 Million Registered Direct Offering 11/10/2015
Mylan (MYL) Highly Confident In Successful Completion Of Tender Offer For Perrigo (PRGO) On Friday 11/10/2015
Isis Pharma (ISIS) Earns $2.8m For Advancing Isis-Dmpk-2.5 Rx In Patients With Myotonic Dystrophy Type I 11/10/2015
Aminex Therapeutics, Inc. Closes $4M Series A Financing 11/10/2015
Perrigo (PRGO) Reaffirms Views On Mylan (MYL)'s Inadequate Offer; Maintains Strong Recommendation Shareholders Not Tender 11/10/2015
Globus Medical (GMED) To Host Analyst Day Meeting Thursday, November 12th 11/10/2015
Enzymotec To Host A VAYA Pharma Analyst And Investor Day In New York City On November 19, 2015 11/10/2015
Baxter International (BAX) (BAX) Declares $0.115 Quarterly Dividend; 1.2% Yield 11/10/2015
Seres Therapeutics Reports Third Quarter 2015 Financial Results And Provides Business Update 11/10/2015
Goldman, Sachs & Co. Forced Valeant (VRX) CEO to Sell $1.3 Million Shares of Company 11/9/2015
Therabron Therapeutics Receives Accelerated Second Tranche From Series B Financing And Expands Investor Syndicate 11/9/2015
Perrigo (PRGO) Responds to Misleading Statements 11/9/2015
Perrigo (PRGO) Issues Shareholder Letter 11/9/2015
Proteon Therapeutics, Inc. (PRTO) To Host Research And Development Day On November 20, 2015 11/9/2015
Revance Therapeutics (RVNC) Announces Closing Of Public Offering Of Common Stock 11/9/2015
PRANA Biotechnology (PRAN) Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price Requirement 11/9/2015
Regeneus (RGS.AX) (ASX:RGS) Chairman's Address And CEO Presentation To Shareholders 11/9/2015
Nextech Invest Portfolio Company Kura Oncology Completes Public Offering At NASDAQ 11/9/2015
Stellar Biotechnologies, Inc. Commences Trading On NASDAQ 11/9/2015
Feds Investigate Eli Lilly (LLY), Merck & Co. (MRK) Over Drug Pricing Policies 11/9/2015
As Biogen (BIIB) Cuts 11% of Staff, Company Doubles Down on Clinical Trials 11/6/2015
Vascular Biogenics Ltd. Announces Closing Of $15 Million Underwritten Offering Of Ordinary Shares And Warrants 11/6/2015
Cancer Genetics (CGIX) Prices Public Offering Of Securities 11/6/2015
Neptune Technologies & Bioressources Inc. Provides Business Update 11/6/2015
Probiodrug AG Completes Capital Increase 11/6/2015
Marinus Pharmaceuticals (MRNS) Announces Public Offering Of Common Stock 11/6/2015
Valeant (VRX) Issues Statement On Sales Of Company Stock 11/6/2015
AmerisourceBergen (ABC) Increases Dividend 17 Percent 11/6/2015
Quintiles (Q) Board Increases The Company’s Share Repurchase Authorization 11/6/2015
Columnist Reveals Letter That Shows Theranos CEO May Have Tried to Take Control From Shareholders 11/5/2015
EnteroMedics (ETRM)Announces $25.0 Million Registered Direct Offering Of Convertible Notes 11/5/2015
BioAmber Inc. Announces Operational And Financial Results For Q3 2015 11/5/2015
Bloomage BioTech Announces Key Investment By GIC To Build Up The Aesthetic Medical Ecosystem In China 11/5/2015
The Manufacturer Of The SynCardia Total Artificial Heart Has Hired Investment Bank Canaccord Genuity, Inc. To Advise The BOD On Strategic Alternatives To Maximize Stakeholder Equity 11/5/2015
Kura Oncology Announces Pricing Of Public Offering Of Common Stock 11/5/2015
Viking Therapeutics (VKTX) Reports Third Quarter 2015 Financial Results And Provides Corporate Update 11/5/2015
Abcam plc (ABC.L) Release: AGM Statement 11/5/2015
ChromaDex, Inc. Announces $2,000,000 Registered Direct Offering 11/5/2015
Epigenomics AG Adjusts 2015 Outlook After FDA Response Letter 11/4/2015
Stellar Biotechnologies, Inc. Announces Approval Of NASDAQ Uplisting 11/4/2015
OncoSec Medical Inc. Announces $7.5 Million Registered Direct Offering 11/4/2015
Revance Therapeutics (RVNC) Announces Pricing Of Public Offering Of Common Stock 11/4/2015
VBI Vaccines And SciVac Therapeutics To Live Webcast Joint Conference Call For Shareholders To Discuss Proposed Merger 11/4/2015
Zealand Pharma  (ZEAL.CO) Is Ready To Take Next Steps In A Diligent Growth Strategy For Accelerated Value Creation: From Peptide To Patient 11/4/2015
Egalet Reports Third Quarter 2015 Financial Results And Provides Business Update 11/4/2015
VolitionRX Announces Third Quarter 2015 Financial Results And Business Update 11/4/2015
Allergan (AGN) Outlines Open Science Model And Highlights Key Development Programs At R&D Day 11/4/2015
Big Meetings This Week with GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (SNY) Have Investors on Pins and Needles 11/3/2015
HeartWare (HTWR) Announces Expiration Of Hart-Scott-Rodino Waiting Period In Connection With Acquisition Of Valtech Cardio 11/3/2015
Alimera Sciences (ALIM) Strengthens Financial Position 11/3/2015
Vascular Biogenics Ltd. Announces Pricing Of $15 Million Underwritten Offering Of Ordinary Shares And Warrants 11/3/2015
Oxford Finance Provides $20 Million Senior Debt Facility To Venus Concept 11/3/2015
co.don AG (DX:CNW) Publishes Rights Offer For Capital Increase 11/3/2015
Recipharm AB: Invitation To Presentation Of Recipharm’s Interim Report For The Third Quarter On 5 November 2015 11/3/2015
Citron Declines to Publish Additional Negative Valeant (VRX) Reports, Opts to Send Information to Investigative Reporters Instead 11/3/2015
Ampio Pharmaceuticals, Inc. (AMPE) Intends To Distribute Aytu Bioscience Stock To Ampio Shareholders 11/2/2015
Revance Therapeutics (RVNC) Announces Proposed Public Offering Of Common Stock 11/2/2015
AEterna Zentaris (AEZS) Announces Agreement to Exercise Substantially All Remaining Series B Warrants 11/2/2015
Perrigo (PRGO) Comments On Mylan (MYL)'s Presentation 11/2/2015
Specialised Therapeutics Australia Release: Australian PBS Listing For New Drug To Treat Chronic Myeloid Leukaemia - Iclusig 11/2/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 11/2/2015
ERT Announces November Installments To Webinar Series 11/2/2015
Illumina (ILMN) Announces New $250 Million Share Repurchase Authorization 11/2/2015
Theravance (THRX) Announces Commencement Of Self-Tender Offer For Up To $75,000,000 Of Its Common Stock 11/2/2015
Stellar Biotechnologies, Inc. Announces Results Of Special Meeting Of Shareholders 10/30/2015
Innovus Pharma Added To The OTCQB Venture Index 10/30/2015
Juniper Pharma (JNP), a Successful Massachusetts Biotech Company of Which You’ve Never Heard 10/30/2015
Bio-Techne (TECH) Declares Dividend 10/30/2015
Quotient Limited (QTNTU) Announces Exercise Of 99.6% Of Warrants Prior To Expiration 10/30/2015
Change Of Number Of Shares And Votes In Karolinska Development AB 10/30/2015
co.don AG (DX:CNW) Plans Capital Increase Of Up To Euro 2,494,976 From Authorized Capital 10/30/2015
Sanofi (SNY)'s New CEO to Deliver Revival Plan After Being Hit by Lagging Sales and Rumors of Boardroom Rows 10/29/2015
HEALTHSOUTH Announces Intent To Redeem $50 Million Of Senior Notes Due 2022 10/29/2015
Vital Therapies (VTL) Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Underwriter's Option To Purchase Additional Shares 10/29/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Analyst Report Update Issued By SeeThruEquity, LLC 10/29/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Qualification For Trading On The OTCQX And Nasdaq Notice Of Delisting 10/29/2015
Lonza Group Ltd. (LZAGY.PK) Reports Positive Momentum In Q3 And Continues Path Of Stabilization 10/29/2015
Kura Oncology Announces Launch Of Public Offering Of Common Stock 10/29/2015
GTx, Inc. (GTXI) Provides Corporate Update And Reports Third Quarter 2015 Financial Results 10/29/2015
Capital Increase Deutsche Biotech Innovativ AG: First Public Offer To Private Investors 10/29/2015
MyoKardia Announces Pricing Of Initial Public Offering 10/29/2015
Endologix Announces Pricing of $110 Million Of Convertible Notes 10/28/2015
Cannabis Science Inc. Positions Itself To Issue Dividend Payouts To Its Shareholders 10/28/2015
Anavex (AVXL) Commences Trading On NASDAQ Today – To Ring Friday’s Closing Bell 10/28/2015
Gilead (GILD) Announces Fourth Quarter 2015 Dividend 10/28/2015
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $11.5 Million 10/28/2015
Pharming Group (PHGUF.PK) Release: Interim Report January - September 2015 10/28/2015
Circassia (CIR.L) Business Update 10/27/2015
Endologix Announces Proposed $150 Million Convertible Senior Notes Offering 10/27/2015
OncoSec Medical Inc. Issues Annual Letter To Shareholders 10/27/2015
CTI BioPharma Prices Underwritten Public Offering Of $50 Million Of Convertible Preferred Stock 10/27/2015
Dyax Corp. (DYAX) To Webcast 2015 Research And Development Day 10/27/2015
Elder Pharmaceutical Ltd. Reaffirms Commitment To Clear All Dues By Raising Funds Through Asset Sale Or Debt Or Issue Of Equity 10/27/2015
Leading Independent Advisory Firms ISS And Glass Lewis Recommend Shareholders Of AEterna Zentaris (AEZS) Vote FOR Share Consolidation 10/27/2015
Prominent Fund Manager Urges GlaxoSmithKline (GSK) to Break Up 10/27/2015
Five Things Investors Want to Know When Pfizer (PFE) Reports Its Q3 10/26/2015
Four Blockbuster Drugs Whose Sales Could Easily Double 10/26/2015
Investors Hold Their Breath as Amgen (AMGN) Inches Toward U.S. Approval for Its New Cancer Immunotherapy T-Vec 10/26/2015
Concordia Healthcare (CXR.TO) Announces Preliminary 2016 Guidance 10/26/2015
CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock 10/26/2015
MannKind Corporation (MNKD) Announces Termination Of Stock Lending Agreement 10/26/2015
HEALTHSOUTH Declares Dividend On Common Stock 10/26/2015
Skystar Bio-Pharmaceutical (CGPN) Announces Receipt Of Nasdaq Notification Letter 10/26/2015
Nordic Nanovector ASA – MANDATORY NOTIFICATION OF TRADE 10/26/2015
Anavex (AVXL) Announces Uplisting To NASDAQ 10/26/2015
Imprimis (immy) Announces New Economic Study Demonstrating $8.7 Billion In Potential Cost Savings Over The Next 10 Years With The Adoption Of Dropless Therapy 10/26/2015
Martin Shkreli Tweets He Has Taken a "Long Position" on Valeant (VRX) Stock 10/23/2015
Under Pressure, GlaxoSmithKline (GSK)'s CEO Shows Off Innovation and Nixes the Possibility of Costly M&As 10/23/2015
How Much Do Boston-Area Pharma Companies Spend on R&D? 10/23/2015
Shire (SHPG) Terminates Milestone Payments to Former Lumena Shareholders After Liver Drug Fails 10/23/2015
MannKind Corporation (MNKD) Announces Dual Listing on the Tel Aviv Stock Exchange 10/23/2015
NovaBay (NBY) Announces Pricing Of Public Offering Of Common Stock And Warrants 10/23/2015
Dechra Pharmaceuticals PLC: Trading Update 10/23/2015
Stellar Biotechnologies, Inc. Issues Corporate Update 10/23/2015
Centene Corporation Announces Overwhelming Shareholder Approval Of Merger With Health Net 10/23/2015
Oasmia Announces Pricing Of Public Offering Of American Depositary Shares And NASDAQ Listing 10/23/2015
Perrigo (PRGO) to Chop 800 Jobs, Buy Back Shares to Fend Off Mylan (MYL) 10/22/2015
Sucampo (SCMP) Closes $250 Million Credit Facility 10/22/2015
WaferGen Biosystems Announces Successful Completion Of $17.25 Million Public Offering 10/22/2015
Mesoblast (MSB.AX) Chairman's Address To 2015 Annual General Meeting 10/22/2015
Merus Labs International Inc. Announces Filing of Audited June 30, 2015 Financial Statements 10/22/2015
BioElectronics Corporation Chairman Letter To Shareholders 10/22/2015
Xizang Haisco Pharma Invests $10 Million In Endospan Of Israel 10/22/2015